Opportunities for Generic Manufacturers in the Top Five European Countries

 

Regular Price: USD 3,950

Special Price USD 2,765

30% OFF

* Required Fields

Regular Price: USD 3,950

Special Price USD 2,765

PAY BY INVOICE

Be the first to review this product

The objective of this research service is to provide detailed analysis of European generic drugs market and to assess the opportunities for generic drug manufacturers in top five European countries.

Table of Contents

Opportunities for Generic Manufacturers in the Top Five European Countries, Executive SummaryExecutive SummarySummary of Generic Drugs Market in Top Five European CountriesOpportunities for Generic Manufacturers in the Top Five European Countries, Abbreviations and Key DefinitionsAbbreviationsAbbreviationsKey Definitions (Source: European Generic Medicines Association)Key DefinitionsOpportunities for Generic Manufacturers in the Top Five European Countries, IntroductionIntroductionOverviewRegulationsOpportunities for Generic Manufacturers in the Top Five European Countries, Market DynamicsKey Industry ChallengesKey Industry ChallengesKey Market Drivers and RestraintsKey DriversKey RestraintsOpportunities for Generic Manufacturers in the Top Five European Countries, Market Engineering Research for European Generic Drugs MarketMarket Engineering Research for European Generic Drugs MarketBackgroundMarket Engineering Research Measurement SystemTotal European Generic Drugs MarketGeographic TrendsGeneric Drugs Market in GermanyGeneric Drugs Market in the United KingdomGeneric Drugs Market in FranceGeneric Drugs Market in SpainGeneric Drugs Market in ItalyOpportunities for Generic Manufacturers in the Top Five European Countries, Competitive AnalysisCompetitive AnalysisCompetitive AnalysisCompany ProfilesOpportunities for Generic Manufacturers in the Top Five European Countries, Strategic Analysis and RecommendationsStrategic Analysis and RecommendationsStrategic RecommendationSWOT Analysis - German Generic Drugs MarketSWOT Analysis - United Kingdom Generic Drugs MarketSWOT Analysis - French Generic Drugs MarketSWOT Analysis - Spanish Generic Drugs MarketSWOT Analysis - Italian Generic Drugs MarketAttractiveness of Generic MarketsThree Levels of StrategiesOpportunities for Generic Manufacturers in the Top Five European Countries, Frost & Sullivan AwardsFrost & Sullivan AwardsIntroductionMarket Leadership AwardCompetitive Strategy Leadership AwardGrowth Strategy Leadership AwardOpportunities for Generic Manufacturers in the Top Five European Countries, Decision Support DatabasesDecision Support DatabasesGovernment Healthcare ExpenditurePrivate Healthcare ExpenditureTotal Healthcare ExpenditurePer Capita Healthcare ExpenditurePharmacists




Related Research

Release Date : 18-Sep-17

Region : Europe

Release Date : 15-Sep-17

Region : Europe

Release Date : 08-Sep-17

Region : Europe

Release Date : 06-Sep-17

Region : Europe

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.